Background: Now-a-days, drug design is an important area of research in medicinal chemistry and theoretical aspects of it basically involve molecular docking. Therefore, a detailed knowledge of drug targets, de facto of proteins/enzymes, is essential and thus it has created interest in the study of protein structure and its flexible nature.
INTRODUCTION
It is now well known that proteins represent major targets for drug discovery. Drug discovery is based on the concept that drugs can bind with the proteins and inhibit their over-activation, which otherwise become the cause of some diseases. Earlier, it was assumed that proteins had fixed conformation, i.e. a single stable state, able to accommodate only one optimal complementary ligand. This system was known as "lock-and-key" model of the binding. However, when a ligand is introduced in a receptor the whole environment is *Address correspondence to this author at the Meerut Institute of Engineering and Technology, Meerut-250005, India; Tel: +91-8889534745; E-mail: spgbits@gmail.com changed to accommodate each other. This is known as "induced-fit" model. Otherwise, a single protein structure would identify only those ligands which will fit in it. This is in fact a constraint to obtain new leads and properly evaluate the existing inhibitors and therefore the receptors must possess multiple structures, thus it was proposed that a protein structure must be flexible, vis-à-vis having a rigid state, to acquire desired states to accommodate the ligands with favorable free energy. Here the concept of "lock-and-key" demanded a rethinking to accommodate variation in three-dimensional structures of macromolecules, i.e., flexibility in their structures. Now people try to find out to what extent the flexibility should be considered to have desired drugreceptor binding. Protein flexibility has now become an essential requirement in drug-receptor interac-tions, where macromolecules must undergo the energetically favorable conformational changes. It leads the macromolecule to undergo conformational changes, many of them being energetically favorable. To account for these conformational changes, per se protein flexibility, various docking methods have been developed. They enable us to find out if a drug molecule will have any opportunity to have the optimum interaction with the protein or enzyme. Nonetheless, study of protein flexibility is a challenging task rather to be applied to discover the potent drugs. Anyway, we have just begun to go a long way. This chapter is just to throw some light on protein flexibility and its importance in drug design.
A HISTORICAL PERSPECTIVE TO "IN-

DUCED-FIT" THEORY VS "LOCK-AND-
KEY MODEL"
At the time when we knew little about enzyme and nothing about active site, Emil Fischer, German Chemist, wrote in 1894: "To use a picture, I would like to say that enzyme and glucoside have to fit to each other like a lock and key in order to exert a chemical effect on each other" [1] . This theory was popularized as 'lock-and-key model' and was found useful to explain experimental observations made by researchers at the time. For years this theory remained unquestionable till a number of biochemical phenomena emerged that could not be explained by this theory. Years later, it was conceptualized that enzyme's catalytic action takes place only in a small region which could be named as 'active site', and that a bigger part of the enzyme was just meant to keep the active site in the correct position. During this time only, enzymes could be recognized as proteins that play catalytic roles in all the chemical reactions within the cells.
As the time passed and the concept of enzymes and the active sites in them were firmly established, a necessity was felt to modify the 'lock-and-key' model. The puzzling problem was as to how one should explain with lock-and-key model the noncompetitive inhibition of the enzyme where the inhibitor does not bind in the active site but away from it and inhibits the binding of the substrate. This gave birth of the concept of the 'induced-fit' model, initially thought of by Koshland. This model envisages the precise orientation of the catalytic groups in the active site, which would require a noticeable change in the three dimensional structure of the active site upon substrate binding [2] . Such a change would not take place if a non-substrate binds. However, this induced-fit model was initially not accepted till the refined X-ray crystallography was not used to study the protein structure. As the X-ray crystallography improved, it became possible to measure small movements of chemicals in the active site. Thus, the induced-fit model was getting support, but the 60-year old lock-and-key model was not totally disregarded but a rethinking about the model itself was required so that it could accommodate the flexibility of enzymes. In fact, as the technology improved and computer modeling developed, a necessity was felt even to refine the theories of Haldane and Koshland, and consequently some researchers proposed a theory to be called 'shifting specificity model'. Now, it is thought that enzyme action requires even greater disorder and flexibility. As the computer technology and software design advanced, our knowledge about enzyme structure and action also advanced. Now computers can predict the three-dimensional structures of enzymes and their active sites and scientists can design molecules that can have optimum interactions with the enzymes and affect their catalytic actions.
Embracing the selecting conformation (better called as conformational selection model), an idea of selecting conformation, population, or fluctuation was developed, where fluctuations in proteins simply meant varying conformations, out of which the ligand will select one which is energetically most favorable [3] . This idea of Strauss was experimentally supported by Zavodszky et al. in 1966 [4] . In this selecting conformation model (better called as conformational selection model), the active and inactive forms are supposed to exist in equilibrium, where vast majority of protein is in the inactive conformation and when ligand is added it only binds to active form and the equilibrium shifts towards the active conformation. In the induced-fit-model, ligand binds to the protein, supposedly to its initially inactive form and the weak interactions between the ligand and the protein induce a conformational change in protein and lead to its active form. Thus the surmise about the conformational change is that while in induced-fit model it is assumed to happen after the binding, in conformational selection model it is assumed to happen before the binding. However, much later to the idea of conformational selection, a theory of 'energy landscape of proteins' was proposed by Frauenfelder et al. [5] to be called as 'conformational selection and population shift' [6, 7] .
According to Vogt et al. [8] , conformational selection is based on kinetic behaviors and forms the basis of explaining the mechanism of ligand binding and relaxation kinetics studied for a large number of systems, while induced-fit model is not so well related to kinetics and was found to be unable explain certain drug-receptor interactions. That macromolecules possess conformational ensembles from which a ligand can select to have the optimal interactions to produce a biological response could be supported only by conformational selection model and not by any other model and thus the conformational selection model is well accepted to explain the mechanism of ligand binding. Fig. (1) schematically explains the difference between induced-fit and conformational selection models. Fig. (1) . A schematic representation of induced-fit and conformational selection models explaining the difference between the two. Reprinted with permission from ref [8] . Copyright 2013 American Chemical Society.
PROTEIN FLEXIBILITY
Before we enter into the discussion of protein flexibility and drug design, it is necessary to define certain basic terms such as catalytic domain, active site and catalytic residues. Proteins are long polymeric chains constituted of amino acids. A catalytic domain is the portion of the enzyme that contains the active site. An active site is the location where the substrates bind. Many proteins have multiple domains. When enzyme-substrate interaction takes place, the amino acid residues of active site can be involved in various types of interactions, such as hydrogen bonding, hydrophobic interactions, electronic interactions, and/or steric interactions.
Residues in enzymes that can contribute to enzyme function are defined as catalytic residues. They contribute to enzyme function by binding to substrate or cofactors, by maintaining the structure of the active site, or by being involved in catalysis. Residues are defined as catalytic only if they play any role in catalytic mechanism. However, it is not essential that an enzyme must have catalytic residues. Some may need only cofactors, e.g., deacetoxycephalosporin-C synthase, which catalyzes a complex, multi-step redox reaction using only an iron cofactor [9] . Catalytic residues also help the ligand come close to the active site residues for proper interactions.
The basic premise of the well concluded drugreceptor binding models, 'induced-fit' and 'conformational selection and population shift' is that the proteins are flexible, thus the flexibility of the macromolecules has become the locus of all bioinformatics theme. Now, it has become almost essential to consider flexibility of proteins to understand their functions and mechanism. Most proteins can undergo local or global conformational change to perform their functions. X-ray and Nuclear Magnetic Resonance (NMR) spectroscopy have greatly helped in determining the protein structures possessing local flexibility, regional flexibility, global flexibility, ability to go from helical conformation to extended conformation, shear motion and domain motion. The local flexibility involves the deviation of protein structures from equilibrium state due to random fluctuations of chemical bonds and bond angles. Regional flexibility involves intra-domain multiresidue coupling which may be due to intramolecular interactions such as hydrogen bonding, ionic bonding, and van der Waals interactions (Fig. 2) . Transitions between such structures occur [10] . Global flexibility refers to formation of hinges between the termini of two secondary structures, e.g., α-helix and β-sheet, or shear motions due to a small sliding movement of domain interfaces that depends upon amino acid side chains within the interface.
Proteins also undergo the change from helical structure to extended conformation and vice-versa at the site of a domain. This change may involve the splitting of the α-helix that can split into two smaller, almost perpendicular, helices separated by four residues of an extended strand [11, 12] . Proteins that have layered structures, stacking of secondary structures, are capable of undergoing the shear motions. It has been found that there may be a common relationship between the positioning of the active site and the two principal protein subdomains in structurally different, but functionally similar, enzymes. Such enzymes have their catalytic site located close to the interface separating the two principal quasi-rigid domains [13] . This positioning of the catalytic site might be necessary to maintain the precise geometry of the active site without disturbing the appreciable functionally oriented modulation of the flanking regions that results from the relative motion of the two subdomains.
Fig. (2).
A network of alternative conformations in a protein (catalase, PDB code: 1GWE) which may be a function of hydrogen bonds (dotted green lines) that may involve water molecules also, van der Waals interactions (blue dots and line segments) between sidechains, coupling through the locally mobile backbone (black), and perhaps electrostatic forces between the Lys (green) and nearby polar residues (blue: Glu, yellow: Asp, purple: Ser).
Taken from [https://en.wikipedia.org/wiki/Protein_dynamics] Almost all the interactions between proteins and any chemicals are associated with conformational changes. Allosteric regulation is related to conformationally flexible regulatory proteins. The role of the enzymes to accelerate the biochemical processes is attributed to their ability to undergo the conformational change [14] . The reduction in free energy barrier and the acceleration of the enzymatic reaction are an attribute of the flexibility of the active site [15] [16] [17] . Till the catalytic process continues, the enzyme molecule undergoes several conformational changes along with the changes in the conformation of the active site. Conformational flexibility of the enzyme has been argued to play important roles in making the active site accessible to substrates and ligands and binding with it, releasing the products and changing turnover rate of the substrates [reviewed in [18] [19] [20] .
According to Najmanovich et al. [21] , side chain flexibility is an important event in ligand binding. It has been observed that there is at least one side chain in more than 50% of the binding sites that undergoes conformational changes upon ligand binding followed by the rotations in side chains up to three residues. However, the flexibility in side chains follows a particular order: Lys > Arg, Gln, Met > Glu, Ile, Leu > Asn, Thr, Val, Tyr, Ser, His, Asp > Cys, Trp, Phe. Thus, Lys side chain in binding pockets has 25 times higher flexibility than a Phe side chain.
An Intrinsic disorder has been defined in protein, which is related to primary amino acid sequence in the protein with disordered regions being rich in small polar and charged residues and deficient in large hydrophobic residues [22, 23] . This intrinsic disorder represents an extreme case of protein flexibility in which entire proteins or regions of proteins do not form stable, folded structures. Proteins that have intrinsic disorder can play a variety of important biological roles [24] [25] [26] [27] [28] [29] . Finally, it is established that proteins can adopt several conformations forming what is called as conformational ensemble.
DETERMINATION OF PROTEIN FLEXI-BILTY AND MOBILITY
For the determination of protein flexibility, X-ray crystallography has been quite popular, but nuclear magnetic resonance (NMR) spectroscopy, or molecular dynamics (MD) methodology has also been applied for it. In X-ray crystallography, the positions of atoms are determined with high accuracy by electron density map, though it deals with a static model of a dynamic object. However, when X-ray crystallography was advanced, it took into consideration the conformational changes in the proteins by introducing the time-resolved methods [30] , such as Laue diffraction, wide-angle X-ray scattering and Xray absorption. The time-resolved methods provided conformational snapshots of the whole protein with atomic detail [31] .
Based on proton spins, NMR spectroscopy was also found to be useful in determining the structure of proteins. In this process, the active nuclei such as 15 N and 13 C are allowed to absorb energy under a magnetic field and then migrate to a higher spin energy level. When they return back to basic level, the emission of energy takes place which is processed to generate proton NMR spectrum. This spectrum can be analyzed to determine the protein structure. Molecular dynamics is a computational method which is based on empirical molecular mechanics potential energy functions. It is used to find the conformation of the proteins in free state as well as in bound state. Computational methods have also been developed to understand the dynamical aspects of enzymatic catalysis [32] . The molecular dynamics approach is a Force FieldBased method. In addition to this molecular dynamics approach, two more methods have been described by Ahmed et al. [33] to account for protein flexibility as described below.
Graph Theoretical Method
Graph theoretical method is used to find rigid and flexible regions from a single, static structure. This method is based on the transformation of atoms and inter-atomic interactions in a protein structure into a bond-bending network so that the atoms could be modelled as nodes and covalent bonds. The noncovalent interactions are represented by edges with distance and angle constraints. Then the pebblegame, a fast combinatorial algorithm, is used to identify the rigid, over-rigid, and flexible regions by counting bond-rotational degrees of freedom in the network. Based on this pebble-game a software known as Floppy Inclusion and Rigid Substructure Topology (FIRST) has been developed [34] . De Groot et al. [35, 36] had developed another method called CONCORD (from CONstraint to COORDinates) to generate conformations by satisfying constraints of fulfilling a set of upper and lower interatomic bounds derived from the experimental structure of the protein.
Harmonic Analysis-Based Methods
To study the large-amplitude molecular motions in proteins, normal mode analysis has been applied. A method known as elastic network model (ENM) has been found suitable to study flexibility of large molecules. This method uses uniform residue-based harmonic potentials in a network of interacting residues instead of any atomic potential and thus it predicts surprisingly accurately large conformational changes, which is difficult with any force-field method.
To account for protein flexibility, proteinligand docking (or molecular docking) has been another approach. This approach studies the position and orientation of a ligand when it is bound in the active site of the enzyme. For this purpose, various docking methods have been devised that take care of the ever-increasing dimensionality. Docking methods are also used in virtual screening of large databases of available chemicals to find drug-like molecules, which can be developed as potent drugs. At present there are four models of docking that can be used to account for both induced-fit and as well as conformational selection models [37, 38] .
Soft Docking
Soft docking has been a very popular approach to account for protein flexibility. It uses interatomic van der Waals interactions in docking calculations [39, 40] , but it takes into account a small degree of overlap between the ligand and the protein. Soft docking is simple in implementation and efficient. However, this approach does not take into account large side-chain rotations or backbone motions. It considers only small conformational changes and has the tendency to increase the rate of false positive.
Selective Docking
Selective docking was developed to account for larger conformational changes, but it is also able to handle only partial flexibility. However, it provides a clear analogy to induced-fit model as it allows the conformational arrangements in the protein to better accommodate the binding. Nonetheless, selective docking requires a detailed knowledge of the structure and function of receptor.
Ensemble Docking
Ensemble docking attempts to dock the ligand into all the conformations of the receptor, instead into a single one. Thus in this docking full flexibility and large-scale conformational changes in the receptor are taken into account. The existing molecular docking program is fully competent to account for conformational ensemble and thus does not require any significant changes. Ensemble docking has been found to provide great improvement over the rigid-protein docking [41] [42] [43] [44] .
On-the-fly Docking
'On-fly-docking' was developed to take into account protein's degrees of freedom in its flexibility which is just contrary to ensemble docking. Here totally new conformations are developed by altering the protein structure. Since in this docking full protein flexibility is considered, attempt should be made to keep the problem computationally feasible maintaining its extremely high dimensionality.
However, it can be said that molecular docking being rapidly evolved has fulfilled a great need of the day. It has been widely applied for drug design but how far it is successful to account for ligand flexibility is still questionable.
PROTEIN FLEXIBILITY AND DRUG DESIGN
Now the theory of protein-ligand binding has greatly shifted from lock-and-key model to induced-fit model. Since the current concept assumes that protein can exist in many conformations, a ligand can bind to any conformation depending upon its shape and size as shown in Fig.  (3) [45] . This means that ligand of any size can be considered to interact with the protein [46] , but a moderate binder will prefer that conformation of the receptor which has the lowest free energy, while a high affinity binder can prefer a conformational state which is well populated as shown in Fig. (3) .
The implications for drug discovery are clear. In order to obtain new leads and properly predict activity of existing inhibitors, multiple structures are the best option. The computational methods developed so far differ in their ability to account for protein flexibility. While considering the protein flexibility in docking, the flexibility of side chains should also be considered and in many cases it has been done. Their torsional freedom also has been included, but involving additional computational cost. However, the methods that consider the flexibility of the entire length of the side chains take into account only rotation around single and double bonds keeping the bond lengths and angles fixed. They can freely access the orientations of side chains through rotations around the bonds. Energy minimization, also called optimization, considering usually all possible orientations of the side chains and ligand leads to strongest contacts between the ligand and the receptor. In most of the minimization procedures, inclusion of side chains has been given preference to the entire protein. However, in order to account for more local flexibility, local backbones in the receptor region should be included [45] . Some novel algorithms developed for some optimization methods try to approach the local minima. However, local backbones in the receptor region can be included for even more local flexibility [45] .
However, to improve the binding affinity of existing inhibitors, the best choice to direct the structural modifications in them is molecular dynamics (MD), a computer simulation method developed to study the physical movements of atoms and molecules. However, for screening large libraries of compounds, soft docking will be the best choice as molecular dynamics can be much slower for this. Due to flexibility of proteins, even structurally similar ligands may have several possible binding modes [47] . Protein flexibility has highly facilitated the drug discovery. In flexible receptors, ligands themselves can find proper binding site and thus different binding sites can be chosen by structurally similar ligands or the same binding site can be used by structurally dissimilar ligands. These both situations are exemplified in Figs. (4 and 5) , respectively. Fig. (4) exhibits the bindings of flufenamic acid and diclofenamic acid with human transthyretin [48] and Fig. (5) exhibits the bindings of four HIV-1 reverse transcriptase inhibitors [49] .The structures of inhibitors are shown in Fig. (6) . Protein flexibility is fully exploited in ligand binding. The protein flexibility and mobility now explain the allosteric inhibition, where the inhibitor changes the shape of the enzyme so that it remains no longer in optimal position to catalyze the reaction [50, 51] . The modern view of allosteric phenomenon [52, 53] conceptualizes an allosteric modulator that changes the population of conformational substates which already exist in global ensemble of the system [53] [54] [55] and which have different binding or signal transduction modes [51, 55] In the induced-fit interaction, amino acids side chains in or near the binding site facilitate the arrangement of the substrate acting as acid or base catalysts. Before the substrate interacts with the active site, the amino acid residues that would participate in the interaction, are brought close together by the conformational change in the protein. These amino acid residues might be widely separated in the primary structure of the protein.
In the enzyme-substrate interaction, various types of interactions such as hydrogen bonding, hydrophobic interactions, electronic interactions, and/or steric interactions can be involved.
It has been pointed out that visualization of a binding site is possible only along with the consideration of its binding partner [56] , i.e. selection of binding site is ligand dependent [57] .
In the binding of any chemical with the protein, only that conformation of the protein is involved in which the binding site has its structure complementary to that of ligand [6] . In a review by Ma et al. [46] it has been concluded that ligands of different sizes, shapes, and composition would certainly require different geometry of the binding sites in the receptor. Not only this, there can also be differences in the movements of backbone and side-chain atoms and in the details of the residue interactions. This conclusion has been supported by observing the structures of bound and unbound states of protein having interacted with ligands of different structures. Thus the ability of a single receptor to recognize many dissimilar ligands permits to subject the diverse molecules to find potent inhibitors of a given protein or enzyme.
The concept of the multiple protein structures is the best option to find new leads [58] . For multiple protein structures flexible docking can be applied with the preference of soft docking, which takes into account the surface plasticity rather than large-scale flexibility. However, the soft docking accounts for only a limited surface plasticity and this is a drawback of this docking, but due to being computationally efficient, it is still preferred. Evaluating the scoring function in it requires no additional calculation time and thus it is relatively easy. However, attempts are still made to further simplify it [59] .
In another docking approach, the ligand is divided into parts, where each part is considered to be relatively a rigid body that can perform hingebending motions among themselves. In the hingebending motion, three operations can be followed: (1) docking the first part (or domain), permitting all degrees of freedom for the second, but it is too costly computationally; (2) docking the parts separately and finding two such parts which can be connected simply by a covalent bond, and (3) adopting docking algorithm [60, 61] , in which all parts are docked simultaneously, yet avoids gridbased searches. However, problem of surface plasticity, thresholds, and the potential presence of too many hinges put a limit on the use of this approach.
All molecular docking procedures are applied to screen a large data base of chemicals to find the members that have a great affinity for given protein. Such molecules may be considered as potential drug candidates. This is known as virtual screening, rather structure-based virtual screening. This is also called as structure-based drug design (or direct drug design). The Ensemble-based docking has been highly preferred for virtual screening.
For molecular docking studies, over the last two decades more than 60 different software tools, as nicely reviewed by Pagadala et al. [62] , have been developed which can be utilized for both academic and commercial purposes, but as of now those found most effective have been MOE-Dock, GOLD, Glide, and FlexX.
So far drug design is concerned, people also adopt ligand-based or indirect drug design which relies on the structure of substrate or other molecules that bind to the biological targets of interest. These other molecules or substrate may be used to derive a pharmacophore model indicating the minimum necessary structural characteristics that must be possessed by a molecule in order to completely bind to the target. This model is then used to de-sign the chemicals that may have effective interactions with the target.
Finally, in drug design where molecular docking is applied the use of scoring functions is made which assess the strength of binding of drugs with the targets. An ideal scoring function must have desired speed and accuracy. As such, scoring functions belong to mainly three different classes: force-field-based scoring functions, empirical scoring functions and knowledge-based scoring functions [63] . Force-field-based scoring functions are the functions of van der Waals and electrostatic interactions, while empirical scoring functions are based on hydrogen bonds, ionic and lipophilic interactions, and the loss of external and configurational entropy upon binding. Knowledge-based scoring functions use the "inverse" Boltzmann law and calculate binding affinity as a sum of proteinligand atom pair interactions.
The force-field scoring functions have the drawback that they estimate the binding energy very roughly and thus they require minimization before use. On the other hand, empirical scoring functions may or may not be able to predict the binding affinity of ligands, structurally different from those used in the training set, and thus one may not be satisfied with any of the scoring functions. Therefore attempt was made to develop a consensus scoring approach from the combination of several scoring functions. In this approach, only the poses receiving high scores by two or more scoring functions are considered [64] . However, different scoring functions have been considered in different docking soft-wares. Ferrara et al. [65] rated nine scoring functions commonly used in docking for a set of around 200 protein-ligand complexes.
CONCLUSION
Protein flexibility has posed now a great challenge in drug design. The drug discovery is now based on induced-fit theory vis-à-vis the lock-andkey theory and thus it has now necessitated the molecular docking. Proteins have no static structure but fluctuate to have several conformations that remain in equilibrium with each other. This is called protein flexibility or protein dynamics. In 3D structure of the protein there exists an active site which is a function of the proper folding of the protein. An enzyme-substrate complex provides a clear picture of the enzyme. There can be several possible binding modes in a flexible protein even for structurally similar ligands. For the determination of protein flexibility, X-ray crystallography, NMR spectroscopy, or molecular dynamics methodology has been used. The structure of the binding site in any protein or enzyme can be determined only when it has its binding partner in it. Of the many conformations possessed by a protein, a ligand will choose only that conformation in which the structure of active site is complementary to its own structure. For drug design several molecular docking methods are available.
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